跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 10,764 条关于
“Waldenström lymphoma”
全部
10,764
临床试验
9,232
药物
135
机构
8
资讯
1,389
8个月前
ImmunityBio's CD19 CAR-NK Therapy Achieves 15-Month Complete Response in Waldenström Lymphoma
9个月前
Imugene Receives FDA Support for Azer-cel CAR-T Therapy Registration Pathway in Lymphoma
去年
Glenmark Pharmaceuticals Receives DCGI Approval to Launch BRUKINSA for Five B-Cell Malignancies in India
去年
BTK Degraders Show Promise in Pretreated B-Cell Malignancies
去年
Imugene's Azer-cel Achieves 75% Response Rate in Phase 1b Trial for Relapsed DLBCL
去年
Schrödinger's SGR-1505 Receives FDA Fast Track Designation for Relapsed Waldenström Macroglobulinemia
去年
NX-5948 Demonstrates Promising Activity in Relapsed/Refractory Waldenström Macroglobulinemia
去年
Iopofosine I 131 Shows Promise in Heavily Pretreated Waldenström Macroglobulinemia
去年
BGB-16673 Shows Promise in Relapsed/Refractory CLL/SLL and Waldenström Macroglobulinemia
去年
Breakthrough Developments in Waldenström Macroglobulinemia Treatment: BTK Inhibitors and Novel Therapies Show Promise
第 1 页,共 139 页
上一页
下一页